35933901|t|Alexander disease GFAP R239C mutant shows increased susceptibility to lipoxidation and elicits mitochondrial dysfunction and oxidative stress.
35933901|a|Alexander disease is a fatal neurological disorder caused by mutations in the intermediate filament protein Glial Fibrillary Acidic Protein (GFAP), which is key for astrocyte homeostasis. These mutations cause GFAP aggregation, astrocyte dysfunction and neurodegeneration. Remarkably, most of the known GFAP mutations imply a change by more nucleophilic amino acids, mainly cysteine or histidine, which are more susceptible to oxidation and lipoxidation. Therefore, we hypothesized that a higher susceptibility of Alexander disease GFAP mutants to oxidative or electrophilic damage, which frequently occurs during neurodegeneration, could contribute to disease pathogenesis. To address this point, we have expressed GFP-GFAP wild type or the harmful Alexander disease GFP-GFAP R239C mutant in astrocytic cells. Interestingly, GFAP R239C appears more oxidized than the wild type under control conditions, as indicated both by its lower cysteine residue accessibility and increased presence of disulfide-bonded oligomers. Moreover, GFP-GFAP R239C undergoes lipoxidation to a higher extent than GFAP wild type upon treatment with the electrophilic mediator 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2). Importantly, GFAP R239C filament organization is altered in untreated cells and is earlier and more severely disrupted than GFAP wild type upon exposure to oxidants (diamide, H2O2) or electrophiles (4-hydroxynonenal, 15d-PGJ2), which exacerbate GFAP R239C aggregation. Furthermore, H2O2 causes reversible alterations in GFAP wild type, but irreversible damage in GFAP R239C expressing cells. Finally, we show that GFAP R239C expression induces a more oxidized cellular status, with decreased free thiol content and increased mitochondrial superoxide generation. In addition, mitochondria show decreased mass, increased colocalization with GFAP and altered morphology. Notably, a GFP-GFAP R239H mutant recapitulates R239C-elicited alterations whereas an R239G mutant induces a milder phenotype. Together, our results outline a deleterious cycle involving altered GFAP R239C organization, mitochondrial dysfunction, oxidative stress, and further GFAP R239C protein damage and network disruption, which could contribute to astrocyte derangement in Alexander disease.
35933901	0	17	Alexander disease	Disease	MESH:D038261
35933901	18	22	GFAP	Gene	2670
35933901	23	28	R239C	ProteinMutation	tmVar:p|SUB|R|239|C;HGVS:p.R239C;VariantGroup:0;CorrespondingGene:2670;RS#:58064122;CorrespondingSpecies:9606;CA#:217208
35933901	95	120	mitochondrial dysfunction	Disease	MESH:D028361
35933901	143	160	Alexander disease	Disease	MESH:D038261
35933901	172	193	neurological disorder	Disease	MESH:D009461
35933901	251	282	Glial Fibrillary Acidic Protein	Gene	2670
35933901	284	288	GFAP	Gene	2670
35933901	353	357	GFAP	Gene	2670
35933901	371	392	astrocyte dysfunction	Disease	MESH:D001254
35933901	397	414	neurodegeneration	Disease	MESH:D019636
35933901	446	450	GFAP	Gene	2670
35933901	517	525	cysteine	Chemical	MESH:D003545
35933901	657	674	Alexander disease	Disease	MESH:D038261
35933901	675	679	GFAP	Gene	2670
35933901	757	774	neurodegeneration	Disease	MESH:D019636
35933901	863	867	GFAP	Gene	2670
35933901	893	910	Alexander disease	Disease	MESH:D038261
35933901	915	919	GFAP	Gene	2670
35933901	920	925	R239C	ProteinMutation	tmVar:p|SUB|R|239|C;HGVS:p.R239C;VariantGroup:0;CorrespondingGene:2670;RS#:58064122;CorrespondingSpecies:9606;CA#:217208
35933901	969	973	GFAP	Gene	2670
35933901	974	979	R239C	ProteinMutation	tmVar:p|SUB|R|239|C;HGVS:p.R239C;VariantGroup:0;CorrespondingGene:2670;RS#:58064122;CorrespondingSpecies:9606;CA#:217208
35933901	1078	1086	cysteine	Chemical	MESH:D003545
35933901	1135	1144	disulfide	Chemical	MESH:D004220
35933901	1177	1181	GFAP	Gene	2670
35933901	1182	1187	R239C	ProteinMutation	tmVar:p|SUB|R|239|C;HGVS:p.R239C;VariantGroup:0;CorrespondingGene:2670;RS#:58064122;CorrespondingSpecies:9606;CA#:217208
35933901	1235	1239	GFAP	Gene	2670
35933901	1297	1333	15-deoxy-Delta12,14-prostaglandin J2	Chemical	MESH:C097240
35933901	1335	1343	15d-PGJ2	Chemical	MESH:C097240
35933901	1359	1363	GFAP	Gene	2670
35933901	1364	1369	R239C	ProteinMutation	tmVar:p|SUB|R|239|C;HGVS:p.R239C;VariantGroup:0;CorrespondingGene:2670;RS#:58064122;CorrespondingSpecies:9606;CA#:217208
35933901	1470	1474	GFAP	Gene	2670
35933901	1512	1519	diamide	Chemical	MESH:D003958
35933901	1521	1525	H2O2	Chemical	MESH:D006861
35933901	1545	1561	4-hydroxynonenal	Chemical	MESH:C027576
35933901	1563	1571	15d-PGJ2	Chemical	MESH:C097240
35933901	1591	1595	GFAP	Gene	2670
35933901	1596	1601	R239C	ProteinMutation	tmVar:p|SUB|R|239|C;HGVS:p.R239C;VariantGroup:0;CorrespondingGene:2670;RS#:58064122;CorrespondingSpecies:9606;CA#:217208
35933901	1628	1632	H2O2	Chemical	MESH:D006861
35933901	1666	1670	GFAP	Gene	2670
35933901	1709	1713	GFAP	Gene	2670
35933901	1714	1719	R239C	ProteinMutation	tmVar:p|SUB|R|239|C;HGVS:p.R239C;VariantGroup:0;CorrespondingGene:2670;RS#:58064122;CorrespondingSpecies:9606;CA#:217208
35933901	1760	1764	GFAP	Gene	2670
35933901	1765	1770	R239C	ProteinMutation	tmVar:p|SUB|R|239|C;HGVS:p.R239C;VariantGroup:0;CorrespondingGene:2670;RS#:58064122;CorrespondingSpecies:9606;CA#:217208
35933901	1843	1848	thiol	Chemical	MESH:D013438
35933901	1885	1895	superoxide	Chemical	MESH:D013481
35933901	1985	1989	GFAP	Gene	2670
35933901	2029	2033	GFAP	Gene	2670
35933901	2034	2039	R239H	ProteinMutation	tmVar:p|SUB|R|239|H;HGVS:p.R239H;VariantGroup:1;CorrespondingGene:2670;RS#:59565950;CorrespondingSpecies:9606;CA#:217209
35933901	2061	2066	R239C	ProteinMutation	tmVar:p|SUB|R|239|C;HGVS:p.R239C;VariantGroup:0;CorrespondingGene:2670;RS#:58064122;CorrespondingSpecies:9606;CA#:217208
35933901	2099	2104	R239G	ProteinMutation	tmVar:p|SUB|R|239|G;HGVS:p.R239G;VariantGroup:0;CorrespondingGene:2670;RS#:58064122;CorrespondingSpecies:9606;CA#:347202
35933901	2208	2212	GFAP	Gene	2670
35933901	2213	2218	R239C	ProteinMutation	tmVar:p|SUB|R|239|C;HGVS:p.R239C;VariantGroup:0;CorrespondingGene:2670;RS#:58064122;CorrespondingSpecies:9606;CA#:217208
35933901	2233	2258	mitochondrial dysfunction	Disease	MESH:D028361
35933901	2290	2294	GFAP	Gene	2670
35933901	2295	2300	R239C	ProteinMutation	tmVar:p|SUB|R|239|C;HGVS:p.R239C;VariantGroup:0;CorrespondingGene:2670;RS#:58064122;CorrespondingSpecies:9606;CA#:217208
35933901	2391	2408	Alexander disease	Disease	MESH:D038261
35933901	Association	MESH:D003545	2670
35933901	Positive_Correlation	MESH:D013481	RS#:58064122;HGVS:p.R239C;CorrespondingGene:2670
35933901	Association	MESH:C027576	RS#:58064122;HGVS:p.R239C;CorrespondingGene:2670
35933901	Positive_Correlation	MESH:D006861	RS#:58064122;HGVS:p.R239C;CorrespondingGene:2670
35933901	Association	MESH:D003958	RS#:58064122;HGVS:p.R239C;CorrespondingGene:2670
35933901	Association	MESH:C097240	2670
35933901	Negative_Correlation	MESH:D006861	2670
35933901	Association	MESH:D028361	RS#:58064122;HGVS:p.R239C;CorrespondingGene:2670
35933901	Association	MESH:C097240	RS#:58064122;HGVS:p.R239C;CorrespondingGene:2670
35933901	Negative_Correlation	MESH:D013438	RS#:58064122;HGVS:p.R239C;CorrespondingGene:2670
35933901	Association	MESH:D028361	2670
35933901	Association	MESH:D038261	2670
35933901	Association	MESH:C027576	2670
35933901	Association	MESH:D038261	RS#:58064122;HGVS:p.R239C;CorrespondingGene:2670
35933901	Association	MESH:D019636	2670
35933901	Positive_Correlation	MESH:D003958	2670
35933901	Association	MESH:D028361	2670
35933901	Association	MESH:D038261	2670

